Targeted agents in the third-/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC)

C.J. Langer, T. Mok, P.E. Postmus

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)252-260
JournalCancer Treatment Reviews
Volume39
Issue number3
DOIs
Publication statusPublished - 2013

Cite this